Dafalgan Dolo Junior, Sirup

7680699040087 CH-69904 Sirup
Dafalgan Dolo Junior, Sirup
Dafalgan Dolo Junior, Sirup
Dafalgan Dolo Junior, Sirup
1 / 3
google

Article details

Package size
150
Selling units
150
Measure
ml
Galenic form
Sirup
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/08/2025
Patient information leaflet
Français
01/08/2025
Patient information leaflet
Italien
01/08/2025
Summary of Product Characteristics
Allemand
01/08/2025
Summary of Product Characteristics
Français
01/08/2025
Summary of Product Characteristics
Italien
01/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
268.0 MG Substance HBESI
(N/A)
- Substance HIMDK
(N/A)
0.17 MG Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
3.54 MG Substance HBESI
(N/A)
- Substance HNIDK

Authorization holder

UPSA Switzerland AG

6300 Zug

Authorization information

Swissmedic authorization number
69904
Drug name
Dafalgan Dolo Junior, Sirup
Galenic form
SIRU
ATC Code
N02BE01
Authorization status
Z
Dispensing category
D
First authorization
06/08/2024
Authorization expiration date
31/12/9999
IT Number
01.01.1.
Domain
Human medicine
Field of application
Analgetikum, Antipyretikum

Package details

Description (FR)
DAFALGAN Dolo Junior siroup 150 ml
Description (DE)
DAFALGAN Dolo Junior Sirup 150 ml
Market launch
07/07/2025
Narcotic (BTM)
No

Other package sizes (7)

None
90 ML
GTIN: None
Not in V1
None
150 ML
GTIN: None
Not in V1
None
90 ML
GTIN: None
Not in V1
None
90 ML
GTIN: None
Not in V1
None
150 ML
GTIN: None
Not in V1
None
150 ML
GTIN: None
Not in V1
None
90 ML
GTIN: None
Not in V1